Mitochondrial bioenergetics stimulates autophagy for pathological tau clearance in tauopathy neurons.
Nuo JiaDhasarathan GanesanHongyuan GuanYu Young JeongSinsuk HanMarialaina NissenbaumAlexander W KusnecovQian CaiPublished in: bioRxiv : the preprint server for biology (2024)
Hyperphosphorylation and aggregation of microtubule-associated tau is a pathogenic hallmark of tauopathies and a defining feature of Alzheimer's disease (AD). Pathological tau is targeted by autophagy for clearance, but autophagy dysfunction is indicated in tauopathy. While mitochondrial bioenergetic failure has been shown to precede the development of tau pathology, it is unclear whether energy metabolism deficiency is involved in tauopathy-related autophagy defects. Here, we reveal that stimulation of anaplerotic metabolism restores defective oxidative phosphorylation (OXPHOS) in tauopathy which, strikingly, leads to enhanced autophagy and pronounced tau clearance. OXPHOS-induced autophagy is attributed to increased ATP-dependent phosphatidylethanolamine biosynthesis in mitochondria. Excitingly, early bioenergetic stimulation boosts autophagy activity and reduces tau pathology, thereby counteracting memory impairment in tauopathy mice. Taken together, our study sheds light on a pivotal role of bioenergetic dysfunction in tauopathy-linked autophagy defects and suggests a new therapeutic strategy to prevent toxic tau buildup in AD and other tauopathies.
Keyphrases
- oxidative stress
- cell death
- endoplasmic reticulum stress
- signaling pathway
- cerebrospinal fluid
- diabetic rats
- machine learning
- type diabetes
- dna methylation
- adipose tissue
- spinal cord
- skeletal muscle
- genome wide
- insulin resistance
- cognitive decline
- deep learning
- working memory
- drug delivery
- drug induced
- spinal cord injury
- high glucose
- protein kinase